Medicare Enrolled
Charles Sidwa, PA
Dermatology · Manahawkin, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Sidwa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Sidwa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Sidwa
Charles Sidwa is a dermatology specialist in Manahawkin, NJ, with 20 years of NPI registration. Based on federal Medicare data, Sidwa performed 4,098 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Sidwa received a total of $7,854 from 28 pharmaceutical and/or device companies across 499 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Sidwa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 25% volume in NJ
$7,854 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,098
Medicare services
Top 25% in NJ for dermatology
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,333 | $5 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
903 | $59 | $196 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
568 | $36 | $149 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
299 | $67 | $228 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $34 | $123 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
178 | $71 | $243 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
98 | $37 | $113 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
50 | $83 | $274 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
42 | $9 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
41 | $85 | $277 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
40 | $42 | $158 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
33 | $226 | $679 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
29 | $69 | $228 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
27 | $57 | $216 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
26 | $98 | $544 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
23 | $130 | $400 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
21 | $35 | $127 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
21 | $102 | $330 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth measuring 0.6 to 1.0 centimeters. It is performed on the scalp, neck, hands, feet, or genitals. |
21 | $98 | $370 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
18 | $103 | $377 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
17 | $68 | $255 |
| Destruction of small cancerous skin growth on face or mouth This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 centimeters or less located on the face, ears, eyelids, nose, lips, or mouth. |
14 | $95 | $311 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $87 | $360 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
11 | $75 | $383 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,854
Total received (2021-2024)
Avg $1,964/year across 4 years
Top 21% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
499
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,076
2023
$2,419
2022
$2,180
2021
$1,179
Payments by company (2024)
ABBVIE INC.
$382
Lilly USA, LLC
$264
Novartis Pharmaceuticals Corporation
$258
Medimetriks Pharmaceuticals, Inc.
$250
LEO Pharma Inc.
$200
GENZYME CORPORATION
$142
SUN PHARMACEUTICAL INDUSTRIES INC.
$108
Amgen Inc.
$84
Regeneron Healthcare Solutions, Inc.
$81
Incyte Corporation
$65
Galderma Laboratories, L.P.
$47
Dermavant Sciences, Inc.
$46
PFIZER INC.
$43
E.R. Squibb & Sons, L.L.C.
$29
MAYNE PHARMA COMMERCIAL LLC
$23
Organogenesis Inc.
$20
Organon Llc
$18
Janssen Biotech, Inc.
$16
Top 3 companies account for 43.5% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,330
Novartis Pharmaceuticals Corporation
$948
Medimetriks Pharmaceuticals, Inc.
$750
Lilly USA, LLC
$699
LEO Pharma Inc.
$671
Regeneron Healthcare Solutions, Inc.
$511
Janssen Biotech, Inc.
$460
GENZYME CORPORATION
$421
Sun Pharmaceutical Industries Inc.
$325
AbbVie Inc.
$322
SUN PHARMACEUTICAL INDUSTRIES INC.
$282
Amgen Inc.
$268
Incyte Corporation
$157
NOVARTIS PHARMACEUTICALS CORPORATION
$155
Journey Medical Corporation
$98
Genentech USA, Inc.
$66
Dermavant Sciences, Inc.
$59
Galderma Laboratories, L.P.
$47
EPI Health, LLC
$46
MAYNE PHARMA COMMERCIAL LLC
$44
PFIZER INC.
$43
E.R. Squibb & Sons, L.L.C.
$42
MAYNE PHARMA INC.
$30
Organogenesis Inc.
$20
Organon Llc
$18
Ortho Dermatologics, a division of Bausch Health US, LLC
$14
Sandoz Inc.
$14
UCB, Inc.
$13
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · APEXICON E · BLU-U · CLODERM · COSENTYX · CYGNUS DUAL · Cimzia · DUPIXENT · ENSTILAR · EUCRISA · Enbrel · Erivedge · HADLIMA · HUMIRA · ILUMYA · Ilumya · JUBLIA · LIBTAYO · Neo-Synalar · OLUMIANT · OPZELURA · Odomzo · Otezla · QBREXZA · REMICADE · RINVOQ · SKYRIZI · Sotyktu · TALTZ · TREMFYA · VTAMA · Winlevi · XOLAIR
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
7
County median income
$86,411
Nearest hospital to ZIP centroid (approximate)
SOUTHERN OCEAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Sidwa is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Sidwa experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Sidwa performed 1,333 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Sidwa receive payments from pharmaceutical companies?
Yes. Sidwa received a total of $7,854 from 28 companies across 499 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Sidwa's costs compare to other dermatologists in Manahawkin?
Sidwa's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Sidwa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Manahawkin
Browse dermatologists in Manahawkin ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NJ
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NJ
Which NJ dermatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Medimetriks Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Medimetriks Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology